| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0f8b21abc3e99d7971c9019578cd9e5c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ed35b7d3c96b10a9f0eec4e87a5c0847
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ae45caa9e39de6b5f702a29df4f4bfea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7717fddfa0f9a8bb762384ad9e0baf44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_628fd2ca6bc94a178798ada0a9188f12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_178b03a93941a657619ed09d63d303c8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_33e635bcaa3e52b19a1b649278a10d8a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7ee8aa67384cb7576ed222ca9b452181 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 |
| filingDate |
2007-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c1517f026ad05b155880971b0c2d841
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_611242e2ca11cf18a8deca44b39604dc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58518ce580d3688084796c3416d41134
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac926b2cb7aa65d5723608e0aeee58cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8db15ea414925aeaaeb39ae8acad1311
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26c3dd55398fb33f676294479d40ca23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b7c8cb70066b1e50853d38a41bb8f5e |
| publicationDate |
2008-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2008083634-A1 |
| titleOfInvention |
1-(2-deoxy-alpha-d-erythro-pentofuranosyl)-5-azacytosine for use as drug |
| abstract |
The invention relates to 1-(2-deoxy-alpha-D-erythro-pentofuranosyl)-5-azacytosine of formula (I) for use as a hypomethylating drug applicable for epigenetic therapy of cancer and other epigenetically determined diseases and further includes the use of the compound of formula (I) for manufacturing of a pharmaceutical composition for epigenetic therapy of cancer and other epigenetically determined diseases. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102313781-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017198288-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11142800-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10301624-B2 |
| priorityDate |
2007-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |